RSS-Feed abonnieren
DOI: 10.1055/s-2001-18683
Increased Renal GLUT1 Abundance and Urinary TGF-β1 in Streptozotocin-Induced Diabetic Rats: Implications for the Development of Nephropathy Complicating Diabetes
Publikationsverlauf
Publikationsdatum:
04. Dezember 2001 (online)
![](https://www.thieme-connect.de/media/hmr/200111/lookinside/thumbnails/10.1055-s-2001-18683-1.jpg)
Increased expression of transforming growth factor beta-1 (TGF-β1) and glucose transporter (GLUT1) has been implicated in the genesis of diabetic nephropathy. The aim of this study was to evaluate GLUT1 protein levels in the renal cortex of a rat model of diabetes as well as its relationship to urinary albumin and TGF-β1. Streptozotocin-injected rats (n = 13) and controls (n = 13) were compared for their urinary albumin, and TGF-β1 and for renal cortical and medullar GLUT1 protein abundance. GLUT1 protein content was determined by optical densitometry after Western blotting using an anti-GLUT1 antibody; urinary albumin was measured using electroimmunoassay, urinary TGF-β1 using ELISA. Forty-five days of diabetes resulted in increased albuminuria (p < 0.05), urinary TGF-β1 (p < 0.05) and GLUT1 protein abundance (p < 0.05). There was a positive correlation between urinary TGF-β1 and plasma glucose levels (r = 0.65, p < 0.05) and albuminuria (r = 0.72, p < 0.05). We concluded that 45 days of diabetes result in incipient diabetic nephropathy and increased cortical GLUT1 protein abundance. We speculate that the higher cortical GLUT1 protein levels in diabetes may amplify the effects of hyperglycemia in determining higher intracellular glucose in mesangial cells, thereby contributing to diabetes-related kidney damage.
Key words:
Diabetic Nephropathy - TGF-β1 - Albuminuria - Streptozotocin - Glucose Transporters
References
- 1 Mauer S M, Steffes M W, Ellis E N, Sutherland D ER, Goetz F C. Structural-functional relationships in diabetic nephropathy. Journal of Clinical Investigation. 1994; 74 1143-1155
- 2 Ayo S H, Radnik R A, Glass W F, Garoni J A, Rampt E R, Appling D R, Kreisberg J I, et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. American Journal of Physiology. 1991; 260 F185-F191
- 3 Ishii H, Tada H, Isogai S. An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-β and protein kinase C activity in cultured human mesangial cells. Diabetologia. 1998; 41 362-364
- 4 Bertoluci M C, Schmid H, Lachat J J, Coimbra T M. Transforming growth factor-beta in the development of rat diabetic nephropathy. Nephron. 1996; 74 189-196
- 5 Mozes M M, Bottinger E P, Jacot T A, Kopp J B. Renal expression of fibrous matrix proteins and of transforming growth factor-beta (TGF-β) isoforms in TGF-β transgenic mice. Journal American Society Nephrology. 1999; 10 271-280
- 6 Bertoluci M C, Schaan B D, Coimbra T M. Increased urinary TGF-β1 in type 2 diabetic patients with diabetic nephropathy (DN). Diabetes. 1998; 47 (Suppl. 1) A129
- 7 Gould G W, Holman G D. The glucose transporter family: structure, function and tissue-specific expression. Biochemical Journal. 1993; 295 329-341
- 8 Heilig C W, Zaloga C, Lee M, Zhao X, Riser B, Brosius F, Cortes P. Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. Laboratory Investigation. 1995; 73 674-684
- 9 Heilig C W, Liu Y, England R L, Freytag S O, Glibert J D, Heilig K O, Zhu M, Concepcion L A, Brosius III F C, et al. D-glucose stimulates mesangial cell Glut1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: Implications for diabetic nephropathy. Diabetes. 1997; 46 1030-1039
- 10 Henry D N, Busik J V, Brosius F, Heilig C W. Glucose transporters control gene expression of aldose reductase, PKC and GLUT1 in mesangial cells in vitro. . American Journal Physiology. 1999; 46 F97-F104
- 11 Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R. TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney International. 1999; 55 1704-1712
- 12 Dominguez J H, Camp K, Maianu L, Feister H, Garvey T. Molecular adaptations of GLUT1 et al: Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. American Journal Physiology. 1994; 266 F282-F290
- 13 Chin E, Zamah A M, Landau D, Gronboeck H, Flyvbjerg A, Leroith D, Bondy C A. Changes in facilitative glucose transporter messenger ribonucleic acid levels in the diabetic rat kidney. Endocrinology. 1997; 138 1267-1275
- 14 Coimbra T M, Furtado M R, Lachat J J, Carvalho I F. Effects of administration of cationic and native homologous albumin in the kidney. Nephron. 1983; 33 208-215
- 15 Machado U F, Shimizu Y, Saito M. Reduced content and preserved translocation of glucose transporter (GLUT4) in white adipose tissue of obese mice. Physiology and Behaviour. 1994; 55 621-625
- 16 Rasch R, Dorup J. Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia. 1997; 40 802-809
- 17 Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Diabetologia. 1980; 18 413-416
- 18 McMahon R J, Frost S. Nutrient control of GLUT1 processing and turnover in 3T3-L1 adipocytes. Journal of Biological Chemistry. 1995; 270 12 094-12 099
- 19 Kaiser N, Sasson S, Feener E P, Boukobza-Vardi N, Higashi S, Moller D E, Davidheiser S, Przybylski R J, King G L. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes. 1993; 42 80-89
- 20 Mayor P, Maianu L, Garvey E T. Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter gene expression. Diabetes. 1992; 41 274-285
- 21 Ortiz P A, Haspel H C. Differential control of the functional cell surface expression and content of hexose transporter GLUT-1 by glucose and glucose metabolism in murine fibroblasts. Biochemical Journal. 1993; 295 67-72
- 22 Comi R J, Hamilton H. Reduction of red cell glucose transporter intrinsic ativity in diabetes running. Hormone Metabolism Research. 1994; 26 26-32
- 23 Chatzilias A A, Whiteside C. Cellular mechanisms of glucose-induced myo-inositol transport upregulation in rat mesangial cells. American Journal Physiology. 1991; 260 F138-F144
Dr. H. Schmid
Curso de Pós-Graduação em Clínica Médica
Universidade Federal do Rio Grande do Sul
Ramiro Barcelos 2350
Porto Alegre, RS
Brasil 90230-035
Telefon: + 55 (51) 333 15 41
Fax: + 55 (51) 333 15 41
eMail: hschmid@terra.com.br